Is anyone into Zi Medical like me ? Gone up a penny today to 7.6p on strength of Sunday Telegraph article - it's looking better, at long last !

been wiating for this for about 3 months...good order book apparently, but bought in at about 7.5 and saw a steady decline to about 4.5 until the last few days...according to the Telegraph could be more in the pipeline so sit tight and may even take a profit soon...

Buckets, Thanks for the info. on the D. Telegragh article (missed it on Sunday)
I got in a year ago at 3.5p and then again a few months ago at 5.75p.. so at long last it'd coming good.. I reckon current price could double over next 3 months or so.
A year ago Shares Mag. highlighted this as a sell when it about 2.5p. It then promptly went up to 4.5p. However. I wouldn't mind betting that over the coming weeks they flag it as a buy. (hopefully it won't go down!)Good luck ! :)

23% up this morning does anyone know why?

I found this on the FT website

Zi Medical Is Dripping with Promise; Partnership Planned with Baxter Health
BY GEOFF FOSTER
No publication details available;



My tip for 2004 is Aim-listed ZI Medical, at 93euro4 pence. It has successfully marketed an intravenous drip monitor called Red-Eye and is to launch it in partnership with Baxter Healthcare.The device has undergone hospital trials and is hoped to earn UKpound 1 million annual sales by 2005.

ZI has an extensive range of fluid delivery products. It is confident of making profits on a monthly basis in the first quarter of 2004.

Founder and chief executive George Gallaher recently bought 30,000 shares at 65euro8 pence. A strong management team includes Dr Robert Nolan, a former director of AstraZeneca. Several major companies are exploring partnerships with ZI to distribute its products globally.

Hi laurencecope,

Many thanks for this.. I was wondering why the share price was increasing nicely this morning.. Do you hold ZIM shares also?
I bought 2 lots. One lot @ 3p a year ago and another lot @ 5.5p 6 months ago.

I'll keep these for tiime being looks as though there's more good news and upward momentum in share price to come....

Good start to the New Year.. Cheers !

Skyhigh

Yes, I bought @6 3 months ago.

I shall also hang on to these for the time being.

Regards
Laurence

These were tipped to me on friday by a friend in the industry who could tell me little as to why. I looked at the fundamentals and struggled to make a case for them so decided not to buy - imagine my horror at seeing them up 30% this morning. I think there was also a tip for them in the mail at the weekend which may have helped the price - good luck to all holders.

Edit - Geoof Foster of the mail tipped it as his share for the year ahead.

Followed SimonCakwell into these months back. Tip now starting to bring home the bacon, jock.

RNS Number:8885T
Zi Medical PLC
06 January 2004



Zi Medical plc ("the Company)"

Disclosable shareholding

The Company was informed on 31 December 2003 that, following a sale of 250,000
ordinary shares of 2p each in the Company on 30 December 2003, Richard Rhys Owen
holds 4,200,000 ordinary shares representing 7.58 per cent of the issued
ordinary share capital of the Company.




This information is provided by RNS
The company news service from the London Stock Exchange

END

Company Zi Medical PLC
TIDM ZIM
Headline Product Launch
Released 07:00 15 Jan 2004
Number 2614U






Zi Medical plc ("Zi Medical or the Company")

UK Product Launch with Baxter Healthcare and

Discussions with Other Medical Device Companies

Zi Medical, the AIM quoted medical devices company, announced today that Baxter Healthcare Corporation ("Baxter") had officially launched the Red-Eye infusion monitor to the UK hospital market. The success of extensive field trials of the product in five major UK hospitals has led to this week's full roll-out to Baxter's UK sales force.

The Company further announces that it is in discussions with two other medical devices companies for the potential exploitation of its medication delivery system.

Michael Fort, Chairman, commented

"The development work carried out during the course of the last 12 months is beginning to bear fruit and Zi Medical has been in discussions with a number of businesses. We are pleased to be able to announce that Zi Medical has signed heads of terms with a large international company for the exclusive rights to a key product in our pipeline and we are confident that this will lead to a firm contract to commercially exploit the product later in the year."

Zi Medical signed an exclusive, global distribution agreement with Baxter in June 2003 for Red-Eye and the product launch in the UK is the companys first step in its strategy to launch a portfolio of innovative and technically superior products to the global healthcare market. Its strategy is to co-develop products in partnership with major medical devices companies who are well placed to achieve rapid penetration of the specialist medical devices market through their well established sales and marketing resources.

Michael Fort commented

"We are delighted to announce the launch of Red-Eye in the UK, the companys first major product to be exploited by a major device company. We are particularly pleased to be partnering a company of the calibre of Baxter whose sales presence in the global market is second to none. Both companies have put a serious effort into ensuring the marketing, training and support offered to customers with Red-Eye is first rate. Although it is too early to say what the financial impact of launch will be on the companys results, we are extremely optimistic that this will be a major contributor to the companys future profitability. In the meantime we will continue to work closely with Baxter to ensure the successful introduction of the product into the UK market."

Press Enquires:


Michael Fort, Executive Chairman,

Zi Medical PLC
Tel: 020 7448 1000

ZoBiddick, Biddicks
Tel: 020 7448 1000


Note to Editors

Red-Eye is an innovative patient monitoring device for the gravity-driven delivery of intravenous solutions. It monitors the safe delivery of intravenous solutions, and can equally be used for administering saline, pharmaceutical products and blood. Red-Eye works by setting off an alarm to alert nursing staff if the flow rate of intravenous fluids fluctuates beyond a predetermined range, thereby permitting staff to carry on other nursing duties. The device can be upgraded with a variety of features such as an illuminated alarm for night use or GSM capability to allow for home care patient monitoring.

END

Hi Lauren,
Thanks for this... looks good and price up a further 2.5p this morning..more to come over the next few weeks/months.. so I'm holding on to my holding of 20k shares for the time being (5k bought at 3.5p & 15k x 5.75p).. not bad going! long may it continue.. :)

Still doing well.. up another 2p today ! Plenty more upside to come thru. Going to keep running.. still lots more good news to come over the coming months on this one..:-)

Now up 3p. Agree that the upside could be very good. Mkt cap still small against potential.

Still going up ! another 2.25p this morning.... not complaining.. but how much more upside is there going to be ? :)

10% rise again today,.
What is everyone elses opinion of how far this is going in the next few weeks.

skyhigh/laurencecope....In at 14 out at 20.5...remembering that old saying that no one ever made a loss taking profit..think the announcement of baxters and talking to others is now built into the SP...
Gem of a company but think it needs to pause for breath..
Good luck to those holding....class product/ distributer..could hit a 1 year end
C

Current upside target is 41p.
No sign of any trend reversal at the moment.
I'm in until it falters.

Densil,
I'm with you as I'm also in until it falters..Is the Current 41p upside target your target ? If not, where did it come from ? I got in at 3p & 6.5p so sitting nicely at the moment but would like to get out at the top. (where ever that is !)

Why look to get out at 41p. Further news is expected any moment. Upside over next 2 - 3 years could be well over a 1.

Still good time to buy if not in already.

Tech,
Agree with the 2/3 yr target >>> 1+
Do you know what the further news will be about ? and when ? are we talking this / next week ?
Cheers!...:)